Weight Loss Jabs: How they’re reshaping life insurance premiums
Originally developed for diabetes, GLP-1 receptor agonists have exploded into the weight-loss market, promising dramatic results. But there’s a question few ask: how do these jabs affect your life insurance premiums?
Christie Insurance
Insuring your business, your interests and your family
Demand for weight-loss injections is unprecedented. According to the National Pharmacy Association, 21% of UK adults tried to access weight-loss treatments last year, rising to 35% among 16–34-year-olds. Social media hype and private prescriptions dominate, while NHS access remains limited to those with severe obesity and co-morbidities. For insurers, this isn’t just a health trend, it’s a risk recalibration that could reshape underwriting models for decades.
Although reduced body weight is generally associated with lower health risks, underwriting decisions are rarely straightforward. One key concern is weight regain. Research from Oxford University indicates that most individuals regain weight within 10 months of discontinuing treatment. To mitigate this risk, many insurers adopt a conservative approach by adding back approximately half of the lost weight when calculating premiums.
Another significant consideration is longevity risk. If these medications lead to sustained improvements in health and life expectancy, insurers may face long-term financial implications. Longer lifespans increase the cost of annuities and other long-duration products, creating challenges similar to those experienced following the decline in smoking prevalence.
In the short term, individuals undergoing treatment or experiencing recent weight changes may encounter conservative pricing due to relapse risk. Over the longer term, once weight stabilises and health indicators improve, premiums could decrease, particularly when medication is combined with sustainable lifestyle changes. Looking ahead, the industry is expected to adopt dynamic underwriting models, integrate wearable technology, and offer discounts for verified adherence to treatment plans.
Practical guidance for life insurance policyholders
- Ensure full disclosure: Transparency is non-negotiable; non-disclosure can invalidate your policy.
- Choose the right timing: Applying after weight stabilisation may result in more favourable rates.
- Adopt a holistic approach: Combining medication with diet and exercise enhances long-term insurability.
- Review your policy regularly: Significant health improvements may justify a premium reassessment.
To find out how we could help you, please call 01908 920570 or email enquiries@christieinsurance.com.
Source: National Pharmacy Association: Pharmacies warn of unsustainable demand for weight-loss medication